PPTA: Ascending Triangle detected on 2 Mar 2026

PPTA is forming an ascending triangle pattern as the company advances toward a final investment decision expected in spring 2026. The stock trades at $36.86, consolidating tightly between resistance at $35.93 and support at $26.52—a 28% trading range. Structure scores 15.0/15, reflecting textbook triangle boundaries. Volume sits at 2.36M shares (+22% above 20-day average), supporting the pattern. Breakout score of 11.7/13 and overall score of 83.9/98 suggest a high-quality setup with 73.74% win probability. The stock's position 357% above its 52-week low underscores the recent rally strength.

H.C. Wainwright raised its price target to $41 from $30 on February 5, 2026, reflecting bullish sentiment on project milestones. Perpetua selected Hatch Ltd. as the EPCM contractor for the Stibnite Gold Project, marking a major transition from planning to development ahead of the spring 2026 final investment decision. The company is securing over $2 billion in financing from the Export-Import Bank of the United States, with a financial decision expected in spring 2026. The project received $80 million in Department of Defense funding and is positioned to produce domestic antimony, a critical mineral for defense. The stock soared approximately 125% in 2025 and is already up nearly 50% in 2026. This momentum is driven by government backing and permitting clarity accelerating development timelines.

A breakout above $35.93 resistance would target $38.72 (conservative measure target)—a 5.2% move from current levels. Volume confirmation is critical; sustained breakout requires volume exceeding 2.36M shares. The pattern invalidates below the support level of $26.52, representing a -28% downside threshold. With 73.74% win probability historically backing ascending triangles at this structural quality, the setup indicates disciplined traders would enter on a close above resistance with stops clearly positioned at support. Breaking higher would align with broader bullish catalysts tied to spring 2026 financing decisions and Final Investment Decision approval.

Critical earnings catalogs may disrupt the pattern: Perpetua will release its next earnings report on March 13, 2026, only 11 days away—high execution risk with a development-stage company. Director Chris J. Robison sold 13,701 shares on January 5-6, 2026, for $360,669 at prices of $26.24-$26.57, signaling insider activity near current levels. Analysts forecast PPTA could fall to $33.00 by February 5, 2027, representing potential downside of 10.47%. RSI at 67.44 approaches overbought territory (70), suggesting momentum may be stretched. The U.S. EXIM Letter of Interest is non-binding and conditional and does not represent a financing commitment, creating regulatory/financing risk. Elevated 6.1% ATR volatility and development-stage fundamentals (current EPS -$0.50) amplify execution risks around spring 2026 milestones.